● Recruiting

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions

Condition: Coronary Disease · Heart Diseases · Cardiovascular Diseases · Sponsor: Teleflex

PhaseNA

Planned participants1859

Who can joinAll sexes, 18 Years to 80 Years

Healthy volunteersNo

About this study

The objective of this study is to assess the safety and efficacy of the Freesolve resorbable magnesium scaffold (RMS) in the treatment of subjects with up to two de novo lesions in native coronary arteries compared to the Xience coronary drug-eluting stent (DES) system

This description comes directly from the study's public registry record.

Talk to the study team

BIOMAG-III Project Manager · 1-866-246-6990 · biomag_us@teleflex.com

Always discuss trial participation with your own doctor first.

Locations (2)

MedStar Washington Hospital Center	Washington D.C., District of Columbia, United States	Recruiting
Charleston Area Medical Center	Charleston, West Virginia, United States	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07258290